cas 23195-62-2|| where to buy 2-(1H-1,2,4-Triazol-3-yl)pyridine

Nom du produit:2-(1H-1,2,4-Triazol-3-yl)pyridine

IUPAC Name:2-(1H-1,2,4-triazol-3-yl)pyridine

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM170751-5g	in stock	ǆǠ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 23195-62-2 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:23195-62-2; Formule moléculaire:C7H6N4; Point de fusion:-; Code SMILES:C1(C2=NNC=N2)=NC=CC=C1; Densité:

: Numéro de catalogue:CM170751; Poids moléculaire:146.15; Point d'ébullition:; N° Mdl:MFCD13188589; Stockage:Store at 2-8°C.

: Pyridines; Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.; Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu; Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer; Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.